Metastasis-Directed Surgery for Solitary Pulmonary Metastasis After Pembrolizumab in Urothelial Carcinoma: A Case Report [0.03%]
针对用派姆单抗治疗后出现的尿路上皮癌孤立性肺转移的转移灶导向手术的一例报告
Kohji Takemura,Makoto Tanaka,Yosuke Hamada et al.
Kohji Takemura et al.
Introduction: The role of metastasis-directed therapy in urothelial carcinoma remains uncertain, particularly in the immune checkpoint inhibitor era. We report a case of solitary pulmonary metastasis that developed after ...
A Case of Acalculous Cholecystitis During Lenvatinib Plus Pembrolizumab Therapy for Advanced Renal Cell Carcinoma [0.03%]
仑伐替尼联合派姆单抗治疗晚期肾细胞癌并发非结石性胆囊炎一例
Erika Soga,Go Noguchi,Kota Kobayashi et al.
Erika Soga et al.
Introduction: Lenvatinib plus pembrolizumab is a standard first-line therapy for advanced renal cell carcinoma (RCC), and acute acalculous cholecystitis is a rare adverse event. ...
Neuroendocrine Transformation Without PSA Elevation in High-Risk Metastatic Castration-Sensitive Prostate Cancer Under Androgen Receptor Signaling Inhibition: A Case Report [0.03%]
高危转移性雄激素敏感型前列腺癌在雄激素受体信号传导抑制下的PSA水平不升高情况下的神经内分泌转化：一例报告
Yoshihiro Nakagami,Shintaro Ohnuma,Masashi Tamaoka et al.
Yoshihiro Nakagami et al.
Introduction: Neuroendocrine prostate cancer is a rare and highly aggressive variant of prostate cancer with a poor prognosis. We report a case in which metastatic castration-sensitive prostate cancer directly transformed...
Adrenal Primary Ganglioneuroblastoma Presenting in Adulthood: A Case Report [0.03%]
成人期出现的原发性肾上腺ganglioneuroblastoma一例报告
Keiichiro Yasuda,Takuji Hayashi,Kentaro Takezawa et al.
Keiichiro Yasuda et al.
Introduction: Ganglioneuroblastoma is a rare neuroblastic tumor derived from embryonic neural crest cells, composed of mature gangliocytes and immature neuroblasts. Although most neuroblastic tumors present in children an...
Belzutifan for Metastatic TFE3-Rearranged Renal Cell Carcinoma With Pulmonary Metastases: A Case Report [0.03%]
关于TFE3重排型转移性肾细胞癌伴肺转移的Belzutifan病例报告
Kazutaka Nakamura,Akihiro Kumono,Yuki Kobari et al.
Kazutaka Nakamura et al.
Introduction: Belzutifan is effective in patients with previously treated advanced clear cell renal cell carcinoma. However, evidence for its use in non-clear cell renal cell carcinoma remains limited. ...
Pathological Complete Response to Nivolumab Plus Ipilimumab Combination Therapy in Advanced Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus [0.03%]
尼伏单抗联合伊匹单抗用于晚期肾细胞癌伴下腔静脉瘤栓的治疗取得病理完全缓解
Takuto Tsuchiya,Go Kimura,Hayato Takeda et al.
Takuto Tsuchiya et al.
Introduction: Nivolumab plus ipilimumab is a standard first-line regimen for advanced renal cell carcinoma; however, primary tumors often respond less favorably to this combination than to immune checkpoint inhibitor-tyro...
Vibegron for Anticholinergic-Resistant Pediatric Neurogenic Lower Urinary Tract Dysfunction After Spinal Cord Amputation: A Case Report [0.03%]
脊髓离断后儿科神经源性下尿路功能障碍抗胆碱能药物治疗无效时使用vibegron的病例报告
Kohei Mori,Izuru Shiba,Haruko Miyazawa et al.
Kohei Mori et al.
Introduction: Pediatric neurogenic lower urinary tract dysfunction (NLUTD) is commonly managed with anticholinergic agents and clean intermittent catheterization (CIC). However, treatment options are limited for patients ...
Rapid Systemic Progression After Ureteroscopic Holmium:YAG Laser Ablation for High-Grade Upper Tract Urothelial Carcinoma in a Solitary Kidney: A Case Report [0.03%]
单侧肾脏高位上尿路尿路上皮癌经尿道钬激光消融术后快速系统性进展一例报告
Shinichi Takebe,Nanaho Demizu,Mei Tokumoto et al.
Shinichi Takebe et al.
Introduction: Endoscopic kidney-sparing management is increasingly being used for upper tract urothelial carcinoma; however, its use in high-grade diseases remains challenging. ...
Concurrent Bladder Urothelial Carcinoma and Prostate Tuberculosis: A Case Report [0.03%]
并发膀胱尿路上皮癌和前列腺结核的病例报告
Rikuo Suzuki,Taketo Kawai
Rikuo Suzuki
Introduction: Tuberculosis is associated with an increased risk of bladder cancer; however, the simultaneous occurrence of urogenital tuberculosis and bladder cancer is rare. Primary prostate tuberculosis is relatively un...
Pseudo-Progression Observed During Immune Checkpoint Inhibitor Therapy for Advanced Adrenocortical Carcinoma [0.03%]
免疫检查点抑制剂治疗肾上腺皮质癌的假性进展现象观察
Moeto Shimoda,Shinji Ohtake,Tetsuya Aoki et al.
Moeto Shimoda et al.
Introduction: Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy. Recent studies suggest that immune checkpoint inhibitors exhibit antitumor activity in selected ACC patients. ...